Re-examination Study for General Vaccine Use to Assess the Safety Profile of ROTATEQ in Usual Practice.

Trial Profile

Re-examination Study for General Vaccine Use to Assess the Safety Profile of ROTATEQ in Usual Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Rotavirus W179-9 vaccine (Primary)
  • Indications Gastroenteritis; Rotavirus infections
  • Focus Adverse reactions
  • Sponsors Merck & Co
  • Most Recent Events

    • 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 19 Oct 2011 Planned number of patients changed from 3473 to 3600 as reported by Clinicaltrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top